BioSniper
ZH
Toggle language
Open menu
Phase 2 Readout
~quarter
Phase 2 Readout: 150
June 30, 2026
Company
4D Molecular Therapeutics, Inc. (FDMT)
Drug
150
Indication
wet AMD
Other upcoming events for FDMT
Phase 3 Readout
Phase 3 Topline: A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of
Feb 1, 2029
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Start Free
Full Calendar
FDMT Overview
PDUFA Dates
Phase 3 Readouts
Phase 2 Readout: 150 — FDMT Phase 2 Readout | BioSniper